Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.

<h4>Background</h4>Hypertension and its consequent end-organ damage including Hypertensive Heart Disease (HHD) are a major concern that impact health, resulting into impairment and reduced quality of life (QOL). The purpose of this study was to describe the burden of HHD in Iran and comp...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Negar Omidi, Jalal Arabloo, Aziz Rezapour, Farshid Alaeddini, Nicola Luigi Bragazzi, Hamid Pourasghari, Masoud Behzadifar, Mojtaba Salarifar, MohammdRafie Khorgami, Seyyed Mojtaba Ghorashi, Samad Azari
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/9ee1dfd151c24ac2b2103cab22f2e9e9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9ee1dfd151c24ac2b2103cab22f2e9e9
record_format	dspace
spelling	oai:doaj.org-article:9ee1dfd151c24ac2b2103cab22f2e9e92021-12-02T20:14:16ZBurden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.1932-620310.1371/journal.pone.0257617https://doaj.org/article/9ee1dfd151c24ac2b2103cab22f2e9e92021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257617https://doaj.org/toc/1932-6203<h4>Background</h4>Hypertension and its consequent end-organ damage including Hypertensive Heart Disease (HHD) are a major concern that impact health, resulting into impairment and reduced quality of life (QOL). The purpose of this study was to describe the burden of HHD in Iran and comparing it with the World Bank upper middle-income countries (UMICs) in terms of disability-adjusted life years (DALY), mortality and prevalence.<h4>Methods</h4>Using data from the Global Burden of Disease study 2017, we compared the number of DALYs, deaths and prevalence trends for HHD from 1990 to 2017 in all age groups for both sex in Iran, and compared the epidemiology and trends with UMICs and globally.<h4>Results</h4>The age-standardized DALY rate for HHD increased by 51.6% for men (95% uncertainty interval [UI] 305.8 to 436.7 per 100,000) and 4.4% for women (95% UI 429.4 to 448.7 per 100,000) in Iran. The age-standardized prevalence of HHD in Iran was almost twice times higher than globally and 1.5-times more than the World Bank UMICs. The age-standardized death rate for HDD increased by 60.1% (95% UI 17.3 to 27.7% per 100,000) for men and by 21.7% (95% UI 25.85 to 31.48 per 100,000) for women from 1990 to 2017. Age-standardized death rate in Iran was 2.4 and 1.9 times higher than globally and UMICs, respectively.<h4>Conclusions</h4>The higher prevalence and death rate in Iran in comparison with UMICs and globally should encourage health care provider to perform intensive screening activities in at risk population to prevent HHD and mitigate its mortality.Negar OmidiJalal ArablooAziz RezapourFarshid AlaeddiniNicola Luigi BragazziHamid PourasghariMasoud BehzadifarMojtaba SalarifarMohammdRafie KhorgamiSeyyed Mojtaba GhorashiSamad AzariPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257617 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Negar Omidi Jalal Arabloo Aziz Rezapour Farshid Alaeddini Nicola Luigi Bragazzi Hamid Pourasghari Masoud Behzadifar Mojtaba Salarifar MohammdRafie Khorgami Seyyed Mojtaba Ghorashi Samad Azari Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
description	<h4>Background</h4>Hypertension and its consequent end-organ damage including Hypertensive Heart Disease (HHD) are a major concern that impact health, resulting into impairment and reduced quality of life (QOL). The purpose of this study was to describe the burden of HHD in Iran and comparing it with the World Bank upper middle-income countries (UMICs) in terms of disability-adjusted life years (DALY), mortality and prevalence.<h4>Methods</h4>Using data from the Global Burden of Disease study 2017, we compared the number of DALYs, deaths and prevalence trends for HHD from 1990 to 2017 in all age groups for both sex in Iran, and compared the epidemiology and trends with UMICs and globally.<h4>Results</h4>The age-standardized DALY rate for HHD increased by 51.6% for men (95% uncertainty interval [UI] 305.8 to 436.7 per 100,000) and 4.4% for women (95% UI 429.4 to 448.7 per 100,000) in Iran. The age-standardized prevalence of HHD in Iran was almost twice times higher than globally and 1.5-times more than the World Bank UMICs. The age-standardized death rate for HDD increased by 60.1% (95% UI 17.3 to 27.7% per 100,000) for men and by 21.7% (95% UI 25.85 to 31.48 per 100,000) for women from 1990 to 2017. Age-standardized death rate in Iran was 2.4 and 1.9 times higher than globally and UMICs, respectively.<h4>Conclusions</h4>The higher prevalence and death rate in Iran in comparison with UMICs and globally should encourage health care provider to perform intensive screening activities in at risk population to prevent HHD and mitigate its mortality.
format	article
author	Negar Omidi Jalal Arabloo Aziz Rezapour Farshid Alaeddini Nicola Luigi Bragazzi Hamid Pourasghari Masoud Behzadifar Mojtaba Salarifar MohammdRafie Khorgami Seyyed Mojtaba Ghorashi Samad Azari
author_facet	Negar Omidi Jalal Arabloo Aziz Rezapour Farshid Alaeddini Nicola Luigi Bragazzi Hamid Pourasghari Masoud Behzadifar Mojtaba Salarifar MohammdRafie Khorgami Seyyed Mojtaba Ghorashi Samad Azari
author_sort	Negar Omidi
title	Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
title_short	Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
title_full	Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
title_fullStr	Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
title_full_unstemmed	Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.
title_sort	burden of hypertensive heart disease in iran during 1990-2017: findings from the global burden of disease study 2017.
publisher	Public Library of Science (PLoS)
publishDate	2021
url	https://doaj.org/article/9ee1dfd151c24ac2b2103cab22f2e9e9
work_keys_str_mv	AT negaromidi burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT jalalarabloo burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT azizrezapour burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT farshidalaeddini burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT nicolaluigibragazzi burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT hamidpourasghari burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT masoudbehzadifar burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT mojtabasalarifar burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT mohammdrafiekhorgami burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT seyyedmojtabaghorashi burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017 AT samadazari burdenofhypertensiveheartdiseaseiniranduring19902017findingsfromtheglobalburdenofdiseasestudy2017
_version_	1718374724199776256

Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017.

Ejemplares similares